Restriction landmark genomic scanning of mouse liver tumors for gene amplification: Overexpression of cyclin A2

Biochemical and Biophysical Research Communications

Volumn 274, Issue 1, 2000, Pages 188-196

  Haddad, Ramsi ^a   Morrow, Arlene D ^a   Plass, Christoph ^a   Held, William A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Cell cycle; DNA amplification; Liver tumorigenesis; Restriction landmark genomic scanning; Transgenic mice

Indexed keywords

CYCLIN A; FIBROBLAST GROWTH FACTOR 2; RESTRICTION ENDONUCLEASE; RNA; VIRUS T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CPG ISLAND; GENE AMPLIFICATION; GENOME; LIVER CARCINOGENESIS; LIVER TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESTRICTION MAPPING; SIMIAN VIRUS 40; SOUTHERN BLOTTING; TRANSGENIC MOUSE;

EID: 0033931540     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3124     Document Type: Article

References (41)

1. Schirmacher P., Held W. A., Yang D., Chisari F. V., Rustum Y., Rogler C. E. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res. 52:1992;2549-2556.
2. Held W. A., Pazik J., O'Brien J. G., Kerns K., Gobey M., Meis R., Kenny L., Rustum Y. Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. Cancer Res. 54:1994;6489-6495.
3. Held W. A., Mullins J. J., Kuhn N. J., Gallagher J. F., Gu G. D., Gross K. W. T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/SV40 T antigen hybrid gene. EMBO J. 8:1989;183-191.
4. Haddad R., Held W. A. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice. Cancer Res. 57:1997;4615-4623.
5. Ohsumi T., Okazaki Y., Okuizumi H., Shibata K., Hanami T., Mizuno Y., Takahara T., Sasaki N., Ueda M., Muramatsu M. Loss of heterozygosity in chromosomes 1, 5, 7 and 13 in mouse hepatoma detected by systematic genome-wide scanning using RLGS genetic map. Biochem. Biophys. Res. Commun. 212:1995;632-639.
6. Akama T. O., Okazaki Y., Ito M., Okuizumi H., Konno H., Muramatsu M., Plass C., Held W. A., Hayashizaki Y. Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status. Cancer Res. 57:1997;3294-3299.
7. Schirmacher P., Held W. A., Yang D., Biempica L., Rogler C. E. Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large tag transgenic mice. Am. J. Pathol. 139:1991;231-241.
8. Okazaki Y., Okuizumi H., Sasaki N., Ohsumi T., Kuromitsu J., Kataoka H., Muramatsu M., Iwadate A., Hirota N., Kitajima M. A genetic linkage map of the mouse using an expanded production system of restriction landmark genomic scanning (RLGS Ver. 1.8). Biochem. Biophys. Res. Commun. 205:1994;1922-1929.
9. Hatada I., Hayashizaki Y., Hirotsune S., Komatsubara H., Mukai T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl. Acad. Sci. USA. 88:1991;9523-9527.
10. Costello J. F., Fruhwald M. C., Smiraglia D. J., Rush L. J., Robertson G. P., Gao X., Wright F. A., Feramisco J. D., Peltomaki P., Lang J. C., Schuller D. E., Yu L., Bloomfield C. D., Caligiuri M. A., Yates A., Nishikawa R., Su Huang H., Petrelli N. J., Zhang X., O'Dorisio M. S., Held W. A., Cavenee W. K., Plass C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns [see comments]. Nat Genet. 24:2000;132-138.
11. Hughes S. J., Glover T. W., Zhu X. X., Kuick R., Thoraval D., Orringer M. B., Beer D. G., Hanash S. A novel amplicon at 8p22-23 results in overexpression of cathepsin B in esophageal adenocarcinoma. Proc. Natl. Acad. Sci. USA. 95:1998;12410-12415.
12. Costello J. F., Plass C., Arap W., Chapman V. M., Held W. A., Berger M. S., Su Huang H. J., Cavenee W. K. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res. 57:1997;1250-1254.
13. Komatsu S., Okazaki Y., Tateno M., Kawai J., Konno H., Kusakabe M., Yoshiki A., Muramatsu M., Held W. A., Hayashizaki Y. Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M). Biochem. Biophys. Res. Commun. 267:2000;109-117.
14. Hayashizaki Y., Hirotsune S., Okazaki Y., Shibata H., Akasako A., Muramatsu M., Kawai J., Hirasawa T., Watanabe S., Shiroishi T. A genetic linkage map of the mouse using restriction landmark genomic scanning (RLGS). Genetics. 138:1994;1207-1238.
15. Gallagher S. R., Smith J. A. One-dimensional gel electrophoresis of protein. Ausubel F. A., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1994;10.2.1-10.2.18 John Wiley & Sons, New York.
16. Winston S. E., Fuller S. A., Hurrel J. G. Western blotting. Ausubel F. A., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1994;John Wiley & Sons, New York.
17. Mouse Genome Database (MGD). 1998;The Jackson Laboratory, Bar Harbor.
18. Manly K. F. A Macintosh program for storage and analysis of experimental genetic mapping data. Mamm. Genome. 4:1993;303-313.
19. Otsuka T., Takayama H., Sharp R., Celli G., LaRochelle W. J., Bottaro D. P., Ellmore N., Vieira W., Owens J. W., Anver M., Merlino G. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res. 58:1998;5157-5167.
20. Kurokawa M., Mitani K., Irie K., Matsuyama T., Takahashi T., Chiba S., Yazaki Y., Matsumoto K., Hirai H. The oncoprotein Evi-1 represses TGF-beta signaling by inhibiting Smad3. Nature. 394:1998;92-96.
21. Chao Y., Shih Y. L., Chiu J. H., Chau G. Y., Lui W. Y., Yang W. K., Lee S. D., Huang T. S. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 58:1998;985-990.
22. Wang J., Chenivesse X., Henglein B., Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature. 343:1990;555-557.
23. Wang J., Zindy F., Chenivesse X., Lamas E., Henglein B., Brechot C. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene. 7:1992;1653-1656.
24. Abraham J. A., Mergia A., Whang J. L., Tumolo A., Friedman J., Hjerrild K. A., Gospodarowicz D., Fiddes J. C. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science. 233:1986;545-548.
25. Mummery C. L., van Rooyen M., Bracke M., van den Eijnden-van Raaij J., van Zoelen E. J., Alitalo K. Fibroblast growth factor-mediated growth regulation and receptor expression in embryonal carcinoma and embryonic stem cells and human germ cell tumours. Biochem. Biophys. Res. Commun. 191:1993;188-195.
26. Nanus D. M., Schmitz-Drager B. J., Motzer R. J., Lee A. C., Vlamis V., Cordon-Cardo C., Albino A. P., Reuter V. E. Expression of basic fibroblast growth factor in primary human renal tumors: Correlation with poor survival. J. Natl. Cancer Inst. 85:1993;1597-1599.
27. Denny P., Lord C. J., Hill N. J., Goy J. V., Levy E. R., Podolin P. L., Peterson L. B., Wicker L. S., Todd J. A., Lyons P. A. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes. 46:1997;695-700.
28. Porras A., Bennett J., Howe A., Tokos K., Bouck N., Henglein B., Sathyamangalam S., Thimmapaya B., Rundell K. A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small-t antigen and is required for transformation in small-t antigen-dependent assays. J. Virol. 70:1996;6902-6908.
29. Morgan D. O. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13:1997;261-291.
30. Sgambato A., Flamini G., Cittadini A., Weinstein I. B. Abnormalities in cell cycle control in cancer and their clinical implications. Tumori. 84:1998;421-433.
31. Zhang Y. J., Jiang W., Chen C. J., Lee C. S., Kahn S. M., Santella R. M., Weinstein I. B. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 196:1993;1010-1016.
32. Alterman R. B., Ganguly S., Schulze D. H., Marzluff W. F., Schildkraut C. L., Skoultchi A. I. Cell cycle regulation of mouse H3 histone mRNA metabolism. Mol. Cell Biol. 4:1984;123-132.
33. Pagano M., Pepperkok R., Verde F., Ansorge W., Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:1992;961-971.
34. Resnitzky D., Hengst L., Reed S. I. Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol. Cell Biol. 15:1995;4347-4352.
35. Keyomarsi K., Pardee A. B. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA. 90:1993;1112-1116.
36. Buckley M. F., Sweeney K. J., Hamilton J. A., Sini R. L., Manning D. L., Nicholson R. I., deFazio A., Watts C. K., Musgrove E. A., Sutherland R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene. 8:1993;2127-2133.
37. Dutta A., Chandra R., Leiter L. M., Lester S. Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer. Proc. Natl. Acad. Sci. USA. 92:1995;5386-5390.
38. Volm M., Koomagi R., Mattern J., Stammler G. Cyclin A is associated with an unfavourable outcome in patients with non-small-cell lung carcinomas. Br. J. Cancer. 75:1997;1774-1778.
39. Paterlini P., Flejou J. F., De Mitri M. S., Pisi E., Franco D., Brechot C. Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters. J. Hepatol. 23:1995;47-52.
40. Berasain C., Patil D., Perara E., Huang S. M., Mouly H., Brechot C. Oncogenic activation of a human cyclin A2 targeted to the endoplasmic reticulum upon hepatitis B virus genome insertion. Oncogene. 16:1998;1277-1288.
41. Nishida N., Fukuda Y., Komeda T., Kita R., Sando T., Furukawa M., Amenomori M., Shibagaki I., Nakao K., Ikenaga M. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54:1994;3107-3110.